AT222274B - - Google Patents

Info

Publication number
AT222274B
AT222274B AT952160A AT952160A AT222274B AT 222274 B AT222274 B AT 222274B AT 952160 A AT952160 A AT 952160A AT 952160 A AT952160 A AT 952160A AT 222274 B AT222274 B AT 222274B
Authority
AT
Austria
Prior art keywords
formaldehyde
inactivation
chelating agent
poliomyelitis
per
Prior art date
Application number
AT952160A
Other languages
German (de)
English (en)
Original Assignee
Behringwerke Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Aktiengesellschaft filed Critical Behringwerke Aktiengesellschaft
Application granted granted Critical
Publication of AT222274B publication Critical patent/AT222274B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT952160A 1959-12-22 1960-12-20 AT222274B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE222274T 1959-12-22

Publications (1)

Publication Number Publication Date
AT222274B true AT222274B (cg-RX-API-DMAC7.html) 1962-07-10

Family

ID=29593366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT952160A AT222274B (cg-RX-API-DMAC7.html) 1959-12-22 1960-12-20

Country Status (1)

Country Link
AT (1) AT222274B (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
KR910002467A (ko) lgM을 함유하는 정맥내 투여용 폴리클로날 면역글로블린 제제 및 이의 제조방법
DE2932604A1 (de) Verfahren zum modifizieren der antigeneigenschaften eines einen quercitinrest enthaltenden graspollen-antigens oder fragments davon, das dabei erhaltene modifizierte graspollen-antigen, dessen verwendung fuer die behandlung von graspollenallergien und das modifizierte graspollen- antigen enthaltende immunotherapeutische mittel
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
DE2457047C3 (de) Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe
DE2355094A1 (de) Tetanus-vaccine und verfahren zu deren herstellung
DE1924304C3 (de) Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren
AT222274B (cg-RX-API-DMAC7.html)
DE1076888B (de) Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke
DE2448530C3 (de) Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
DE68917709T2 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
CH399653A (de) Verfahren zur Inaktivierung von Poliomyelitisviren
CH664575A5 (de) Verfahren zur herstellung eines interferonpraeparates mit antiviraler aktivitaet.
DE2528584A1 (de) Verfahren zur inaktivierung der virusinfektiositaet unter gleichzeitiger stabilisierung von virusantigenen
DE2034118A1 (en) Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
DE2440926C3 (de) Injizierbarer inaktivierter Impfstoff gegen Hepatitis B und Verfahren zu seiner Herstellung
DE543604C (de) Verfahren zur Dauersterilisierung von Heilseren
DE1148037B (de) Verfahren zur Herstellung eines desaggregierten, das Komplementsystem nicht beeinflussenden Gammaglobulins
AT226372B (de) Dessaggregiertes Gammaglobulin und Verfahren zu seiner Herstellung
AT216142B (de) Verfahren zur Herstellung von Depotimpfstoffen
DE1007473B (de) Verfahren zur Herstellung eines Poliomyelitis-Impfstoffes
DE2340911A1 (de) Tetanus-antigen und verfahren zu seiner herstellung
AT200257B (cg-RX-API-DMAC7.html)
AT228398B (de) Verfahren zur Reinigung und Konzentrierung von lebendem Poliomyelitisvirus oder dem entsprechenden Antigenmaterial
DE2225548A1 (de) Intravenoes vertraegliche staupe- und hepatitisvaccine
AT376883B (de) Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern